Skip to content
WeighLab
Menu

Head-to-head · Cost-Efficiency Index

AskRx vs CLYR Health

Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.

Better valueGrade C · #266

AskRx

Patients who specifically want FDA-approved branded Wegovy/Zepbound/Foundayo and don't need to see the drug price before starting intake.

Visit AskRx
VS
Grade C · #271

CLYR Health

Shoppers comparing tirzepatide options who account for the post-first-month price increase rather than anchoring on the $149 headline.

Visit CLYR Health

The verdict

Too close to callGrade C vs C

AskRx and CLYR Health tie on the Cost-Efficiency Index at 59/100, so neither wins outright on the numbers. For most shoppers we'd start with AskRx (ranked #266, a hair above #271) — Patients who specifically want FDA-approved branded Wegovy/Zepbound/Foundayo and don't need to see the drug price before starting intake. But CLYR Health is a genuine coin-flip alternative here.

Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs AskRx.

Factor by factor

Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.

Normalized Cost/Month

45
54

Price Transparency

54
78

Nationwide Access

86
24

Formulation Options

64
79

Clinical Oversight

82
82

Contract Flexibility

20
37

Pricing, coverage & formulary

The disclosed facts behind the scores. Lower price wins its row (teal).

SpecAskRxCLYR Health
Cost-Efficiency Index59/10059/100
Semaglutide / moNot disclosed$169/mo (compounded)
Tirzepatide / moNot disclosed$199/mo (compounded)
Semaglutide / yr (modeled)$2,028
Tirzepatide / yr (modeled)$2,388
CoverageAll 50 statesCoverage not published
Oral / sublingualYesNo
Brand-name accessYesYes
Rank here#266#271

AskRx

59/100

Where the value is

  • Sells only FDA-approved branded medication ('never compounded'), removing compounding-related sourcing questions entirely
  • States a clear, itemized flat care fee ($90 visit + $10 fulfillment = $100/mo) rather than folding an undisclosed markup into the drug price
  • Explicitly states no markup is added to the medication's pharmacy cost

The tradeoffs

  • The actual medication price — the majority of the real monthly cost for a brand-name GLP-1 — is never published; it's shown only at checkout after intake, so the site cannot be used to comparison-shop the true total cost
  • Live video visits are limited to 'select states' despite the blanket '50 States' coverage claim, an inconsistency the site doesn't reconcile
Visit AskRx

Full AskRx review →

CLYR Health

59/100

Where the value is

  • LegitScript Certified badge displayed
  • Named prescribing medical group (MD Integrations, PC) disclosed in Terms of Service
  • 503A-licensed compounding pharmacy referenced

The tradeoffs

  • Tirzepatide headline price ($149) is an explicit first-month-only rate -- real ongoing cost is $199/month
  • Inconsistent states-served claims ('all 50 states' vs. 'ships to 47 states') on the same site
Visit CLYR Health

Full CLYR Health review →

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.

Keep comparing

← All head-to-head comparisons